ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0942

An Aged K/BxA Arthritis Mouse Model Develops Features of Interstitial Lung Disease with Pulmonary Fibrosis and Bronchus-Associated T-Cell Aggregates Without a Pulmonary Insult, and Correlates with Worsening Arthritis Scores

Amir Razmjou1, Richard Watson2, Ani Shahbazian3, Jennifer Wang1 and christina Charles-Schoeman4, 1UCLA, Los Angeles, CA, 2UCLA Medical Center, Los Angeles, CA, 3UCLA, Los Angeles, 4UCLA Medical Center, Santa Monica, CA

Meeting: ACR Convergence 2024

Keywords: interstitial lung disease, Mouse Models, RA, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Rheumatoid Arthritis – Animal Models Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis associated interstitial lung disease (RA-ILD) is a significant extra-articular manifestation of RA with high morbidity/mortality, but the underlying pathogenesis remains poorly understood. There is a relative paucity of mouse models to study RA-ILD. The K/BxAg7 mouse is a well-established animal model for arthritis and cardiovascular disease (Rose S, et al. Ann Rheum Dis, 2013). This study aimed to evaluate the development of ILD in an aged K/BxA mouse model, to evaluate the association of arthritis and ILD, and the relationship of ILD with immune activation measured by lipopolysaccharide binding protein (LBP), and a panel of inflammatory cytokines and chemokines.

Methods: Analysis included 13 aged K/BxA mice (44 weeks +4, 8 (62%) female), and 13 age and sex matched C57BL/6 wild type (WT) controls. Masson’s trichrome staining was performed on the lung tissue and pulmonary fibrosis was calculated via the Ashcroft scoring system by an experienced assessor. CD3 staining of lung tissue was used to assess for bronchus-associated T-cell (BATc) aggregates; this analysis was done by two blinded assessors and the mean score was used. Arthritis was assessed by a blinded assessor using calipers to measure the ankle width of the hindlimbs to calculate a mean hindlimb (mHL) score. Luminex multiplex immunoassays were done for 32 mouse cytokines/chemokines/growth factors, and LBP was measured by ELISA.

Results: Aged K/BxA mice demonstrated significantly higher amounts of pulmonary fibrosis by Ashcroft scoring than did WT mice (mean +SD of 3.1 +0.8, 2.1 +0.8, p=0.004), significantly higher BATc aggregates (8.5 +7.4, 1.3 +1.0, p=0.002), as well as significantly higher mHL scores (428 +45, 301 +4.5, p< 0.0001)(Figure 1). There was significant positive correlations between increasing mHL scores and increased Ashcroft scores (r=0.51, p=0.009), as well as with increased BATc aggregates (r=0.54, p=0.004)(Figure 2). Higher LBP levels correlated significantly with increased mHL scores and Ashcroft scores (r=0.77, p< 0.0001, and r=0.52, p=0.009, respectively), but fell short of significance with BATc aggregates (r=0.34, p=0.09)(Figure 3). Ashcroft scores correlated significantly with increasing TNF-alpha, IL-2, and CCL-3, and correlated negatively with Eotaxin, while BATc aggregates correlated significantly and positively with increasing IL-1(alpha), IL-1(beta), and CXCL-1. There were significantly higher levels of LBP, IL-6, and CXCL-1 in K/BxA mice versus WT.

Conclusion: Without pulmonary insult, aged K/BxA mice developed ILD at higher degrees than matched WT mice, and the ILD mirrored several features of RA-ILD in humans with increased pulmonary fibrosis, bronchus-associated T-cell aggregates. Additionally, as occurs in RA patients with ILD, K/BxA mice demonstrated significant associations between increasing arthritis scores and worsening ILD. Additionally, measures of immune activation, most significant being LBP demonstrated positive associations with ILD. The aged K/BxA mouse model for arthritis may represent a promising model for the study of RA-ILD.

Supporting image 1

Figure 1. Ashcroft Scores and Bronchus-Associated T-Cell Aggregates by Genotype. (A) The left column depicts the differences between Ashcroft scores by mouse genotype status. (B) The right column depicts the differences between bronchus-associated T-cell aggregates (BATc) by mouse genotype. Box-whisker plots overlay data points and include the minimum and maximum values at each tail.

Supporting image 2

Figure 2. Linear Regressions of Ashcroft Scores and Bronchus-Associated T-Cell Aggregates with Mean Hindlimb Scores. (A) Top panel depicts linear regression of mean hindlimb scores as the independent variable, and Ashcroft scores as dependent outcomes. (B) Bottom panel depicts linear regression of mean hindlimb scores as the independent variable, and bronchus-associated T-cell aggregates as dependent outcomes. Pearson’s regressions were used for both models, and showed statistically significant positive correlations. 95% confidence intervals are outlined by the dotted lines.

Supporting image 3

Figure 3. Linear Regressions of Ashcroft Scores and Bronchus-Associated T-Cell Aggregates with Lipopolysaccharide Binding Protein Levels. (A) Top panel depicts linear regression of lipopolysaccharide binding protein levels as the independent variable, and Ashcroft scores as dependent outcomes. (B) Bottom panel depicts linear regression of lipopolysaccharide binding protein levels as the independent variable, and bronchus-associated T-cell aggregates as dependent outcomes. Pearson’s regressions were used for both models, and showed statistically significant positive correlations. 95% confidence intervals are outlined by the dotted lines.


Disclosures: A. Razmjou: None; R. Watson: None; A. Shahbazian: None; J. Wang: None; c. Charles-Schoeman: AbbVie/Abbott, 2, 5, Alexion, 5, Boehringer-Ingelheim, 2, Bristol-Myers Squibb(BMS), 2, 5, CSL Behring, 5, Galapagos, 2, Janssen, 5, Octapharma, 2, 5, Pfizer, 2, 5, Priovant, 5, Recludix, 2.

To cite this abstract in AMA style:

Razmjou A, Watson R, Shahbazian A, Wang J, Charles-Schoeman c. An Aged K/BxA Arthritis Mouse Model Develops Features of Interstitial Lung Disease with Pulmonary Fibrosis and Bronchus-Associated T-Cell Aggregates Without a Pulmonary Insult, and Correlates with Worsening Arthritis Scores [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/an-aged-k-bxa-arthritis-mouse-model-develops-features-of-interstitial-lung-disease-with-pulmonary-fibrosis-and-bronchus-associated-t-cell-aggregates-without-a-pulmonary-insult-and-correlates-with-wor/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/an-aged-k-bxa-arthritis-mouse-model-develops-features-of-interstitial-lung-disease-with-pulmonary-fibrosis-and-bronchus-associated-t-cell-aggregates-without-a-pulmonary-insult-and-correlates-with-wor/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology